Serum sickness-like reaction in pediatric age - experience of an Imunoalergology Unit

Detalhes bibliográficos
Autor(a) principal: Martins, Francisca Rocha
Data de Publicação: 2019
Outros Autores: Pereira, Tatiana, Soares, Diana, Romariz, Jorge, Praça, Fátima, Costa, Herculano, Pedrosa, Cláudia
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://doi.org/10.25753/BirthGrowthMJ.v28.i3.16677
Resumo: Background: Serum sickness is a systemic reaction reported after administration of heterologous serum. It is clinically characterized by fever, skin lesions, arthralgia/arthritis, lymphadenopathy, and nephritis and by presence of immune complexes. Serum sickness-like reaction mimics serum sickness and its pathophysiology is not well understood. It is more common in pediatric age and often associated with drug administration. This study aimed to characterize serum sickness-like reaction cases evaluated at a Drug Allergy Clinic. Material and methods: An analytical, retrospective, longitudinal study of a sample of 39 children (56% male) with diagnosis of serum sickness-like reaction evaluated at a Drug Allergy Clinic between January 2007 and December 2017 was performed. Results: Children had an average of 4.8 years at the time of reaction. In most cases (97%), beta-lactam antibiotics were the suspected triggering drugs. On average, clinical manifestations developed 7.5 days after treatment start. Skin lesions developed in all patients, and arthralgia/arthritis in 92.3%. Fifteen percent of children were hospitalized. Penicillin-specific IgE was evaluated in 87% of patients, but only tested positive in two. Skin prick tests and intradermal tests were performed in 46% of cases and were positive in seven. Oral challenge test was performed in 26% of patients and was positive in three. Conclusion: Serum sickness-like reaction is a rare and poorly understood entity. Diagnosis is essentially clinical, requiring a high index of suspicion. In the acute phase, usefulness of complementary tests lies mainly in the differential diagnosis with other diseases.
id RCAP_613ca0045304ee730e3a9067f19c59a9
oai_identifier_str oai:ojs.revistas.rcaap.pt:article/16677
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Serum sickness-like reaction in pediatric age - experience of an Imunoalergology UnitDoença do soro-like em idade pediátrica - experiência de uma Unidade de ImunoalergologiaOriginal ArticlesBackground: Serum sickness is a systemic reaction reported after administration of heterologous serum. It is clinically characterized by fever, skin lesions, arthralgia/arthritis, lymphadenopathy, and nephritis and by presence of immune complexes. Serum sickness-like reaction mimics serum sickness and its pathophysiology is not well understood. It is more common in pediatric age and often associated with drug administration. This study aimed to characterize serum sickness-like reaction cases evaluated at a Drug Allergy Clinic. Material and methods: An analytical, retrospective, longitudinal study of a sample of 39 children (56% male) with diagnosis of serum sickness-like reaction evaluated at a Drug Allergy Clinic between January 2007 and December 2017 was performed. Results: Children had an average of 4.8 years at the time of reaction. In most cases (97%), beta-lactam antibiotics were the suspected triggering drugs. On average, clinical manifestations developed 7.5 days after treatment start. Skin lesions developed in all patients, and arthralgia/arthritis in 92.3%. Fifteen percent of children were hospitalized. Penicillin-specific IgE was evaluated in 87% of patients, but only tested positive in two. Skin prick tests and intradermal tests were performed in 46% of cases and were positive in seven. Oral challenge test was performed in 26% of patients and was positive in three. Conclusion: Serum sickness-like reaction is a rare and poorly understood entity. Diagnosis is essentially clinical, requiring a high index of suspicion. In the acute phase, usefulness of complementary tests lies mainly in the differential diagnosis with other diseases.Introdução: A doença do soro é uma reação sistémica descrita após administração de soro heterólogo, caracterizada clinicamente por febre, lesões cutâneas, artralgias/artrite, linfadenopatia e nefrite, e laboratorialmente por presença de imunocomplexos. A doença do soro-like mimetiza a doença do soro, não estando a sua fisiopatologia bem estabelecida. É mais frequente em idade pediátrica e surge muitas vezes associada à administração de fármacos. Este estudo pretendeu caracterizar os casos de doença do soro-like avaliados numa consulta de alergia a fármacos. Material e métodos: Este foi um estudo analítico, retrospetivo e longitudinal de uma amostra de 39 crianças (56% do sexo masculino) com diagnóstico de doença do soro-like avaliadas em consulta de alergia a fármacos entre janeiro de 2007 e dezembro 2017. Resultados: A idade média das crianças na altura da reação foi de 4,8 anos. Antibióticos beta-lactâmicos foram os fármacos suspeitos na maioria dos casos (97%). As manifestações clínicas surgiram, em média, 7,5 dias após o início do tratamento. Verificaram-se lesões cutâneas em todos os doentes e atingimento articular em 92,3%. Um total de 15% das crianças foram internadas. Foi efetuado doseamento de IgE específicas em 87% dos doentes, tendo sido positivo em apenas dois. Foram realizados testes cutâneos por picada e intradérmicos em 46% dos casos, com resultados positivos em sete. A prova de provocação oral foi realizada em 26% dos doentes, tendo sido positiva em três. Conclusão: A doença do soro-like é uma patologia rara e pouco estudada. O diagnóstico é essencialmente clínico, sendo necessário um elevado índice de suspeição. A utilidade dos exames complementares reside principalmente no diagnóstico diferencial com outras patologias.Centro Hospitalar Universitário do Porto2019-10-14T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttps://doi.org/10.25753/BirthGrowthMJ.v28.i3.16677eng2183-9417Martins, Francisca RochaPereira, TatianaSoares, DianaRomariz, JorgePraça, FátimaCosta, HerculanoPedrosa, Cláudiainfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2022-09-21T14:55:33Zoai:ojs.revistas.rcaap.pt:article/16677Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T15:56:28.780993Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Serum sickness-like reaction in pediatric age - experience of an Imunoalergology Unit
Doença do soro-like em idade pediátrica - experiência de uma Unidade de Imunoalergologia
title Serum sickness-like reaction in pediatric age - experience of an Imunoalergology Unit
spellingShingle Serum sickness-like reaction in pediatric age - experience of an Imunoalergology Unit
Martins, Francisca Rocha
Original Articles
title_short Serum sickness-like reaction in pediatric age - experience of an Imunoalergology Unit
title_full Serum sickness-like reaction in pediatric age - experience of an Imunoalergology Unit
title_fullStr Serum sickness-like reaction in pediatric age - experience of an Imunoalergology Unit
title_full_unstemmed Serum sickness-like reaction in pediatric age - experience of an Imunoalergology Unit
title_sort Serum sickness-like reaction in pediatric age - experience of an Imunoalergology Unit
author Martins, Francisca Rocha
author_facet Martins, Francisca Rocha
Pereira, Tatiana
Soares, Diana
Romariz, Jorge
Praça, Fátima
Costa, Herculano
Pedrosa, Cláudia
author_role author
author2 Pereira, Tatiana
Soares, Diana
Romariz, Jorge
Praça, Fátima
Costa, Herculano
Pedrosa, Cláudia
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Martins, Francisca Rocha
Pereira, Tatiana
Soares, Diana
Romariz, Jorge
Praça, Fátima
Costa, Herculano
Pedrosa, Cláudia
dc.subject.por.fl_str_mv Original Articles
topic Original Articles
description Background: Serum sickness is a systemic reaction reported after administration of heterologous serum. It is clinically characterized by fever, skin lesions, arthralgia/arthritis, lymphadenopathy, and nephritis and by presence of immune complexes. Serum sickness-like reaction mimics serum sickness and its pathophysiology is not well understood. It is more common in pediatric age and often associated with drug administration. This study aimed to characterize serum sickness-like reaction cases evaluated at a Drug Allergy Clinic. Material and methods: An analytical, retrospective, longitudinal study of a sample of 39 children (56% male) with diagnosis of serum sickness-like reaction evaluated at a Drug Allergy Clinic between January 2007 and December 2017 was performed. Results: Children had an average of 4.8 years at the time of reaction. In most cases (97%), beta-lactam antibiotics were the suspected triggering drugs. On average, clinical manifestations developed 7.5 days after treatment start. Skin lesions developed in all patients, and arthralgia/arthritis in 92.3%. Fifteen percent of children were hospitalized. Penicillin-specific IgE was evaluated in 87% of patients, but only tested positive in two. Skin prick tests and intradermal tests were performed in 46% of cases and were positive in seven. Oral challenge test was performed in 26% of patients and was positive in three. Conclusion: Serum sickness-like reaction is a rare and poorly understood entity. Diagnosis is essentially clinical, requiring a high index of suspicion. In the acute phase, usefulness of complementary tests lies mainly in the differential diagnosis with other diseases.
publishDate 2019
dc.date.none.fl_str_mv 2019-10-14T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://doi.org/10.25753/BirthGrowthMJ.v28.i3.16677
url https://doi.org/10.25753/BirthGrowthMJ.v28.i3.16677
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 2183-9417
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Centro Hospitalar Universitário do Porto
publisher.none.fl_str_mv Centro Hospitalar Universitário do Porto
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130433271627776